Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonists

Bioorg Med Chem Lett. 2019 Aug 15;29(16):2265-2269. doi: 10.1016/j.bmcl.2019.06.036. Epub 2019 Jun 20.

Abstract

An X-ray crystal structure of one of our previously discovered RORγt inverse agonists bound to the RORγt ligand binding domain revealed that the cyclohexane carboxylic acid group of compound 2 plays a significant role in RORγt binding, forming four hydrogen bonding and ionic interactions with RORγt. SAR studies centered around the cyclohexane carboxylic acid group led to identification of several structurally diverse and more potent compounds, including new carboxylic acid analogues 7 and 20, and cyclic sulfone analogues 34 and 37. Notably, compounds 7 and 20 were found to maintain the desirable pharmacokinetic profile of 2.

Keywords: IL-17; Inverse agonist; RORγt; Retinoic acid-related orphan receptor gamma t; Th17.

MeSH terms

  • Administration, Oral
  • Animals
  • Biological Availability
  • Crystallography, X-Ray
  • Dose-Response Relationship, Drug
  • Drug Inverse Agonism
  • Humans
  • Mice
  • Models, Molecular
  • Molecular Structure
  • Nuclear Receptor Subfamily 1, Group F, Member 3 / agonists*
  • Pyrrolidines / administration & dosage
  • Pyrrolidines / chemistry
  • Pyrrolidines / pharmacology*
  • Structure-Activity Relationship
  • Sulfones / administration & dosage
  • Sulfones / chemistry
  • Sulfones / pharmacology*

Substances

  • Nuclear Receptor Subfamily 1, Group F, Member 3
  • Pyrrolidines
  • Sulfones